he EASL SLD Summit 2026 aims at updating you on the most recent advances in Steatotic Liver Disease (SLD) including MASLD, MetALD and ALD research, both pre-clinically and clinically and looking into the potential interaction between the 2 most important drivers of SLD. The Summit is a unique opportunity to exchange with both young fellows and established experts in the field in a highly interactive format with a lot of room for discussion.
Topics: Metabolism, alcohol and toxicity